SMMT icon

Summit Therapeutics
SMMT

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $3.37M invested in Summit Therapeutics in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$150K
2
+$20.6K
3
+$10.4K

Top Sellers

1
-$44K
2
-$41K
3
-$20K
4
Deutsche Bank
Deutsche Bank
Germany
-$10.1K
5
PC
Polar Capital
United Kingdom
-$6.73K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.02M
2
$436K
3
$309K
4
$274K
5
$220K
6
$107K
7
$2K
8
$1K
9
$1K
10
$1K
11
–
12
–
13
–